Literature DB >> 18692472

The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation.

Guido Hansen1, Timothy R Hercus, Barbara J McClure, Frank C Stomski, Mara Dottore, Jason Powell, Hayley Ramshaw, Joanna M Woodcock, Yibin Xu, Mark Guthridge, William J McKinstry, Angel F Lopez, Michael W Parker.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine that controls the production and function of blood cells, is deregulated in clinical conditions such as rheumatoid arthritis and leukemia, yet offers therapeutic value for other diseases. Its receptors are heterodimers consisting of a ligand-specific alpha subunit and a betac subunit that is shared with the interleukin (IL)-3 and IL-5 receptors. How signaling is initiated remains an enigma. We report here the crystal structure of the human GM-CSF/GM-CSF receptor ternary complex and its assembly into an unexpected dodecamer or higher-order complex. Importantly, mutagenesis of the GM-CSF receptor at the dodecamer interface and functional studies reveal that dodecamer formation is required for receptor activation and signaling. This unusual form of receptor assembly likely applies also to IL-3 and IL-5 receptors, providing a structural basis for understanding their mechanism of activation and for the development of therapeutics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692472     DOI: 10.1016/j.cell.2008.05.053

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  132 in total

1.  Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury.

Authors:  Xiaonan Han; Shila Gilbert; Katherine Groschwitz; Simon Hogan; Ingrid Jurickova; Bruce Trapnell; Charles Samson; Jonathan Gully
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

2.  Analysis of the immune response to sciatic nerve injury identifies efferocytosis as a key mechanism of nerve debridement.

Authors:  Ashley L Kalinski; Choya Yoon; Lucas D Huffman; Patrick C Duncker; Rafi Kohen; Ryan Passino; Hannah Hafner; Craig Johnson; Riki Kawaguchi; Kevin S Carbajal; Juan Sebastian Jara; Edmund Hollis; Daniel H Geschwind; Benjamin M Segal; Roman J Giger
Journal:  Elife       Date:  2020-12-02       Impact factor: 8.140

Review 3.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

Review 4.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

5.  Targeting F box protein Fbxo3 to control cytokine-driven inflammation.

Authors:  Rama K Mallampalli; Tiffany A Coon; Jennifer R Glasser; Claire Wang; Sarah R Dunn; Nathaniel M Weathington; Jing Zhao; Chunbin Zou; Yutong Zhao; Bill B Chen
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

6.  Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3.

Authors:  Shamaruh Mirza; Jinglong Chen; Bin Wen; Cameron L Ewens; Jin Dai; James M Murphy; Ian G Young
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

7.  A conserved sugar bridge connected to the WSXWS motif has an important role for transport of IL-21R to the plasma membrane.

Authors:  P Siupka; O T Hamming; L Kang; H H Gad; R Hartmann
Journal:  Genes Immun       Date:  2015-06-04       Impact factor: 2.676

Review 8.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 9.  Emerging cell and cytokine targets in rheumatoid arthritis.

Authors:  Gerd R Burmester; Eugen Feist; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2013-11-12       Impact factor: 20.543

10.  ZO-1 expression is suppressed by GM-CSF via miR-96/ERG in brain microvascular endothelial cells.

Authors:  Hu Zhang; Shuhong Zhang; Jilin Zhang; Dongxin Liu; Jiayi Wei; Wengang Fang; Weidong Zhao; Yuhua Chen; Deshu Shang
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-21       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.